SonarMD, a leading value-based care (VBC) platform for chronic gastrointestinal conditions, has presented new findings at the Advances in Inflammatory Bowel Diseases (AIBD) conference in Orlando, Florida (9–11 December 2024). The research highlights the significant relationship between anxiety and higher disease severity in inflammatory bowel disease (IBD), underscoring the need for mental health support within VBC models.

The study used data from patients participating in SonarMD’s care coordination platform. This platform extends gastroenterology practices by integrating patient engagement, disease monitoring, and risk assessment. The findings reveal the impact of anxiety on IBD patients' health outcomes.

Key Study Insights

• Prevalence of Anxiety Symptoms: Among 643 IBD patients, 11.8% exhibited symptoms of anxiety, indicated by a Generalised Anxiety Disorder (GAD-2) score of 3 or higher.
• Depression as a Comorbidity: Anxiety symptoms were strongly linked to depressive symptoms, with nearly half (49%) of patients with anxiety also meeting criteria for depression based on the PHQ-2 score.
• Increased Disease Severity: Patients with anxiety were more likely to experience severe disease, with 42% falling into the top quintile of disease risk compared to 15% of those without anxiety.
• Higher Risk of Flares: Over six months, patients with anxiety had a 25% flare rate compared to 13% in those without anxiety symptoms.

The research highlights the importance of addressing mental health factors in IBD care. Patients with anxiety face heightened risks of disease exacerbation and poorer health outcomes.

SonarMD’s findings demonstrate the benefits of a multidisciplinary approach to IBD care within value-based frameworks. By incorporating mental health screening and support tools, care models can more effectively address the interconnected physical and psychological challenges faced by patients.

The results support the integration of mental health care as a standard component of high-quality IBD management. SonarMD’s scalable VBC model integrates mental health tools to enhance patient outcomes while streamlining care delivery.

This research was presented on 11 December during the AIBD conference at the Walt Disney World Swan & Dolphin Resort in Orlando, Florida.

 

 

Source: businesswire.com

Report Abuse